524520

- Investor Presentation for KMC Speciality Hospitals (India) Limited for the quarter ended 30th June, 2026 (Q1 FY2027).

- Approval for new capacity expansion projects. Trichy Campus to add ~500 beds for Rs. 486 Cr (Q4 FY28, Q2 FY30). Bengaluru Mother & Child Hospital to add ~91 beds for Rs. 33 Cr (Q2 FY28). M/s. G Sugumar & Co appointed as Cost Auditor for FY 2026-27.

- Q1 FY27 Standalone Revenue ₹91.78Cr vs ₹66.55Cr (▲38% YoY) - EBITDA ₹28.49Cr vs ₹16.45Cr (▲73% YoY) - PAT ₹16.57Cr vs ₹7.54Cr (▲120% YoY) - EBITDA Margin 31.04% vs 24.72% (▲632bps)

- Q1 FY27 Standalone Revenue ₹91.78 Cr vs ₹66.55 Cr (▲37.9% YoY) - EBITDA ₹30.29 Cr vs ₹17.25 Cr (▲75.6% YoY) - PAT ₹16.57 Cr vs ₹7.54 Cr (▲120.1% YoY) - EBITDA Margin 33.0% vs 25.9% (▲708bps)

- Catalyst Trusteeship disclosed encumbrance on 46.93% of Sri Kauvery Medical Limited (SKMCIL) shares by promoters, comprising a 14.53% pledge and a 32.40% non-disposal undertaking. This secures debentures issued by Prospera Healthcorp Private Limited. SKMCIL holds 75% of KMC Speciality Hospitals.

- Board Meeting scheduled for Friday, 14th August, 2026. - To consider and approve unaudited financial results for the quarter ended 30th June, 2026.

- Promoter Sri Kauvery Medical Care (India) Limited (SKMCIL) disclosed indirect encumbrance on its shares, which hold 75% of KMC Speciality Hospitals (India) Limited. - This encumbrance (pledge and non-disposal undertaking) totals ~46.93% of SKMCIL's shares. - It secures Non-Convertible Debentures issued by Prospera Healthcorp Private Limited.

- Trading window for Designated Persons is closed from July 1, 2026. - It will remain closed until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. - This is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.